Evidence map›Paper›PMID 30571978›Full record

ArticleJournal of molecular and cellular cardiology2019

Cardiomyocyte cell cycle dynamics and proliferation revealed through cardiac-specific transgenesis of fluorescent ubiquitinated cell cycle indicator (FUCCI).

Roberto Alvarez, Bingyan J Wang, Pearl J Quijada, Daniele Avitabile, Thi Ho, Maya Shaitrit, Monica Chavarria, Fareheh Firouzi, David Ebeid, Megan M Monsanto and 7 more

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. In Vivo Methods to Monitor Cardiomyocyte Proliferation.Journal of cardiovascular development and disease · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Roberto AlvarezSDSU Heart Research Institute, San Diego State University, 5500 Campanile Drive, San Diego, CA 92182, USA.
Bingyan J WangSDSU Heart Research Institute, San Diego State University, 5500 Campanile Drive, San Diego, CA 92182, USA.
Pearl J QuijadaSDSU Heart Research Institute, San Diego State University, 5500 Campanile Drive, San Diego, CA 92182, USA.
Daniele AvitabileSDSU Heart Research Institute, San Diego State University, 5500 Campanile Drive, San Diego, CA 92182, USA.
Thi HoSDSU Heart Research Institute, San Diego State University, 5500 Campanile Drive, San Diego, CA 92182, USA.
Maya ShaitritSDSU Heart Research Institute, San Diego State University, 5500 Campanile Drive, San Diego, CA 92182, USA.
Monica ChavarriaSDSU Heart Research Institute, San Diego State University, 5500 Campanile Drive, San Diego, CA 92182, USA.
Fareheh FirouziSDSU Heart Research Institute, San Diego State University, 5500 Campanile Drive, San Diego, CA 92182, USA.
David EbeidSDSU Heart Research Institute, San Diego State University, 5500 Campanile Drive, San Diego, CA 92182, USA.
Megan M MonsantoSDSU Heart Research Institute, San Diego State University, 5500 Campanile Drive, San Diego, CA 92182, USA.
Natalie NavarreteSDSU Heart Research Institute, San Diego State University, 5500 Campanile Drive, San Diego, CA 92182, USA.
Maryam MoshrefSDSU Heart Research Institute, San Diego State University, 5500 Campanile Drive, San Diego, CA 92182, USA.
Sailay SiddiqiSDSU Heart Research Institute, San Diego State University, 5500 Campanile Drive, San Diego, CA 92182, USA.
Kathleen M BroughtonSDSU Heart Research Institute, San Diego State University, 5500 Campanile Drive, San Diego, CA 92182, USA.
Barbara A BaileySDSU Department of Mathematic and Statistics, San Diego State University, 5500 Campanile Drive, San Diego, CA 92182, USA.
Natalie A GudeSDSU Heart Research Institute, San Diego State University, 5500 Campanile Drive, San Diego, CA 92182, USA.
Mark A SussmanSDSU Heart Research Institute, San Diego State University, 5500 Campanile Drive, San Diego, CA 92182, USA. Electronic address: heartman4ever@icloud.com.
San Diego State University · US

Funding

Surgery, Physiology and ImmunohistopathologyP01HL085577 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2006 to 2017
$18.4M
Regulation of Signal Transduction to Treat Heart FailureR01HL067245 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2001 to 2021
$6.0M
Stem Cell Signaling in the Pathologically Challenged MyocardiumR37HL091102 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2008 to 2017
$3.8M
Beta-adrenergic signaling: double edged sword of myocardial repairR01HL117163 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2013 to 2017
$1.9M
Antagonism of myocardial aging and senescence with Pim-1 kinaseR01HL105759 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2011 to 2015
$1.8M
Resolving myocardial regeneration by tracking commitment of c-Kit+ cellsR01HL135661 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI GUDE, NATALIE ALLEN, SUSSMAN, MARK ALAN · 2017 to 2020
$1.7M
Enhanced Myocardial Repair with CardioClusters and CardioChimerasR01HL122525 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2014 to 2017
$1.5M
Cardioprotection by optimizing mTOR activityR01HL113647 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2013 to 2016
$1.5M
Chromatin Content and Regenerative Potential of Cardiac Progenitor CellsF32HL136196 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI BROUGHTON, KATHLEEN · 2017 to 2018
$118k
NHLBI NIH HHS F32 HL136196NHLBI NIH HHS L30 HL138888NHLBI NIH HHS P01 HL085577NHLBI NIH HHS R01 HL067245NHLBI NIH HHS R01 HL105759NHLBI NIH HHS R01 HL113647NHLBI NIH HHS R01 HL117163NHLBI NIH HHS R01 HL122525NHLBI NIH HHS R01 HL135661NHLBI NIH HHS R37 HL091102
6 · The paper itself

Abstract

rationaleUnderstanding and manipulating the cardiomyocyte cell cycle has been the focus of decades of research, however the ultimate goal of activating mitotic activity in adult mammalian cardiomyocytes remains elusive and controversial. The relentless pursuit of controlling cardiomyocyte mitosis has been complicated and obfuscated by a multitude of indices used as evidence of cardiomyocyte cell cycle activity that lack clear identification of cardiomyocyte "proliferation" versus cell cycle progression, endoreplication, endomitosis, and even DNA damage. Unambiguous appreciation of the complexity of cardiomyocyte replication that avoids oversimplification and misinterpretation is desperately needed.

objectiveTrack cardiomyocyte cell cycle activity and authenticate fidelity of proliferation markers as indicators of de novo cardiomyogenesis in post-mitotic cardiomyocytes. METHODS AND

resultsCardiomyocytes expressing the FUCCI construct driven by the α-myosin heavy chain promoter were readily and uniformly detected through the myocardium of transgenic mice. Cardiomyocyte cell cycle activity peaks at postnatal day 2 and rapidly declines thereafter with almost all cardiomyocytes arrested at the G1/S cell cycle transition. Myocardial infarction injury in adult hearts prompts transient small increases in myocytes progressing through cell cycle without concurrent mitotic activity, indicating lack of cardiomyogenesis. In comparison, cardiomyogenic activity during early postnatal development correlated with coincidence of FUCCI and cKit

conclusionsCardiomyocyte-specific expression of Fluorescence Ubiquitination-based Cell Cycle Indicators (FUCCI) reveals previously unappreciated aspects of cardiomyocyte cell cycle arrest and biological activity in postnatal development and in response to pathologic damage. Compared to many other methods and model systems, the FUCCI transgenic (FUCCI-Tg) mouse represents a valuable tool to unambiguously track cell cycle and proliferation of the entire cardiomyocyte population in the adult murine heart. FUCCI-Tg provides a desperately needed novel approach in the armamentarium of tools to validate cardiomyocyte proliferative activity that will reveal cell cycle progression, discriminate between cycle progression, DNA replication, and proliferation, and provide important insight for enhancing cardiomyocyte proliferation in the context of adult myocardial tissue.

Indexed as

Cell CycleGene Transfer TechniquesUbiquitinationAnimalsAnimals, NewbornCell Cycle CheckpointsCell DivisionCell ProliferationCells, CulturedFluorescenceHeartMice, TransgenicMyocytes, CardiacOrgan SpecificityCardiomyocyteCell-cycleFUCCIMyocardial infarctRegeneration

Identifiers

PMID30571978
PMCPMC6588545
OpenAlexW2904335762

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.